Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
N1-Tikun Olam-Mood support
- Development stage
- Unknown
- Lead developer
- Tikun Olam
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
N1-Tikun Olam-Mood support is a specialized cannabis-derived formulation developed by Tikun Olam, a global leader in medical cannabis research. Designed specifically for mood enhancement and emotional regulation, this product utilizes a proprietary blend of cannabinoids and terpenes derived from Tikun Olam's extensively researched cannabis strains. The formulation typically targets the endocannabinoid system, primarily acting on Cannabinoid receptor 1 (CB1) and Cannabinoid receptor 2 (CB2) to modulate neurotransmitter release and inflammatory responses associated with mood regulation. While marketed in the United States as a wellness product for mood support, it leverages Tikun Olam's clinical heritage in developing standardized cannabinoid ratios for therapeutic applications. The product is intended to provide a balanced effect that supports emotional well-being without the intense psychoactivity often associated with high-THC products.
- Brand names
- N1N-1N 1
- Other names
- N1 botanical cannabis formulationN-1 botanical cannabis formulationN 1 botanical cannabis formulation
02
Targets
CNR1 (Cannabinoid receptor 1)FAAHHTR1A (Serotonin receptor 1A (5-hydroxytryptamine receptor 1A))
Beyond the preview
Go deeper on N1-Tikun Olam-Mood support.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on N1-Tikun Olam-Mood support.